QIAGEN powered by
Analyze whole genome sequencing samples at the speed of light

QIAGEN Digital Insights Monday, November 28, 2022

Introducing a new way to improve bioinformatics efficiency in your high-throughput NGS setting It’s exciting that advancements in high-throughput sequencing…

Study shows clinical decision support software exceeds consistency among variant scientists

QIAGEN Digital Insights Wednesday, October 26, 2022

Peer-reviewed study compares accuracy and consistency of variant assessments from commercial CDS software to the internal variant interpretation methods of…

Boost your agility and speed in drug development

QIAGEN Digital Insights Thursday, September 15, 2022

Looking for flexible ways to integrate high-quality ‘omics data? Execute detailed queries via API, download flat files or use the…

Cell line characterization and selection made easy

QIAGEN Digital Insights Monday, August 29, 2022

Build confidence and efficiency into your preclinical pipeline with traceable and high-quality cell line ‘omics data from a trusted source…

Take the legwork out of drug toxicity screening

QIAGEN Digital Insights Tuesday, June 7, 2022

How to easily create, manage and share adverse outcome pathways to accelerate drug discovery programs Scientists working in drug discovery…

Know your biomarkers: How PRKD1 is linked to head and neck squamous cell carcinoma (HNSCC)

QIAGEN Digital Insights Tuesday, May 31, 2022

COSMIC v96 adds new oncogene that may be beneficial to diagnose HNSCC Head and neck cancers are a heterogeneous collection…

Scale your exome workflow with Dr. Atil Bisgin at ESHG 2022

QIAGEN Digital Insights Thursday, May 19, 2022

Have you reserved your in-person or virtual spot at the European Human Genetics Conference (ESHG) held June 11-14, 2022, in…

Three easy ways to process your expression data to gain biological insights

QIAGEN Digital Insights Tuesday, April 26, 2022

Do you ever struggle to formulate hypotheses based on your experimental expression data? You may be comparing results from healthy…

How to track the progress of ERBB2-targeted therapies from early case studies to market with COSMIC Actionability

QIAGEN Digital Insights Monday, April 25, 2022

The latest COSMIC Actionability release is here with a focus on the ERBB2 gene. Before we delve into the trove…

Accelerate your data science-driven drug discovery: Announcing QIAGEN Biomedical Knowledge Base

QIAGEN Digital Insights Monday, April 25, 2022

You need biomedical relationships knowledge for innovative data- and analytics-driven drug discovery. Yet this knowledge is locked in thousands of…

New Content Release: HGMD Professional 2022.1

QIAGEN Digital Insights Tuesday, March 29, 2022

More mutations, better annotations, confident classifications HGMD Professional 2022.1 is now available, expanding the world’s largest collection of human inherited disease…

Using knowledge graphs to drive drug discovery

QIAGEN Digital Insights Tuesday, March 29, 2022

Have you ever done a Google search to find a restaurant or look up what your favorite actor is up…